Guillain-Barre Syndrome Treatment Market, Global Outlook and Forecast 2022-2028

July 2022 | 68 pages | ID: GECE2BBFD355EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Guillain-Barre Syndrome Treatment in Global, including the following market information:

Global Guillain-Barre Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Guillain-Barre Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunoglobulin Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Guillain-Barre Syndrome Treatment include CSL Limited, Grifols S A, Octapharma AG, Kedrion Biopharma Inc and Biotest AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Guillain-Barre Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Guillain-Barre Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Guillain-Barre Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)

• Immunoglobulin Therapy
• Plasma Exchange (Plasmapheresis)

Global Guillain-Barre Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Guillain-Barre Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Guillain-Barre Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Guillain-Barre Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Guillain-Barre Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Guillain-Barre Syndrome Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• CSL Limited
• Grifols S A
• Octapharma AG
• Kedrion Biopharma Inc
• Biotest AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Guillain-Barre Syndrome Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Guillain-Barre Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GUILLAIN-BARRE SYNDROME TREATMENT OVERALL MARKET SIZE

2.1 Global Guillain-Barre Syndrome Treatment Market Size: 2021 VS 2028
2.2 Global Guillain-Barre Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Guillain-Barre Syndrome Treatment Players in Global Market
3.2 Top Global Guillain-Barre Syndrome Treatment Companies Ranked by Revenue
3.3 Global Guillain-Barre Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Guillain-Barre Syndrome Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Guillain-Barre Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Guillain-Barre Syndrome Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Guillain-Barre Syndrome Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Guillain-Barre Syndrome Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Guillain-Barre Syndrome Treatment Market Size Markets, 2021 & 2028
  4.1.2 Immunoglobulin Therapy
  4.1.3 Plasma Exchange (Plasmapheresis)
4.2 By Type - Global Guillain-Barre Syndrome Treatment Revenue & Forecasts
  4.2.1 By Type - Global Guillain-Barre Syndrome Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Guillain-Barre Syndrome Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Guillain-Barre Syndrome Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Guillain-Barre Syndrome Treatment Revenue & Forecasts
  5.2.1 By Application - Global Guillain-Barre Syndrome Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Guillain-Barre Syndrome Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Guillain-Barre Syndrome Treatment Market Size, 2021 & 2028
6.2 By Region - Global Guillain-Barre Syndrome Treatment Revenue & Forecasts
  6.2.1 By Region - Global Guillain-Barre Syndrome Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Guillain-Barre Syndrome Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Guillain-Barre Syndrome Treatment Revenue, 2017-2028
  6.3.2 US Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.3.3 Canada Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.3.4 Mexico Guillain-Barre Syndrome Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Guillain-Barre Syndrome Treatment Revenue, 2017-2028
  6.4.2 Germany Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.4.3 France Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.4.4 U.K. Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.4.5 Italy Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.4.6 Russia Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.4.8 Benelux Guillain-Barre Syndrome Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Guillain-Barre Syndrome Treatment Revenue, 2017-2028
  6.5.2 China Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.5.3 Japan Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.5.4 South Korea Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.5.6 India Guillain-Barre Syndrome Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Guillain-Barre Syndrome Treatment Revenue, 2017-2028
  6.6.2 Brazil Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.6.3 Argentina Guillain-Barre Syndrome Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Guillain-Barre Syndrome Treatment Revenue, 2017-2028
  6.7.2 Turkey Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.7.3 Israel Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Guillain-Barre Syndrome Treatment Market Size, 2017-2028
  6.7.5 UAE Guillain-Barre Syndrome Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 CSL Limited
  7.1.1 CSL Limited Corporate Summary
  7.1.2 CSL Limited Business Overview
  7.1.3 CSL Limited Guillain-Barre Syndrome Treatment Major Product Offerings
  7.1.4 CSL Limited Guillain-Barre Syndrome Treatment Revenue in Global Market (2017-2022)
  7.1.5 CSL Limited Key News
7.2 Grifols S A
  7.2.1 Grifols S A Corporate Summary
  7.2.2 Grifols S A Business Overview
  7.2.3 Grifols S A Guillain-Barre Syndrome Treatment Major Product Offerings
  7.2.4 Grifols S A Guillain-Barre Syndrome Treatment Revenue in Global Market (2017-2022)
  7.2.5 Grifols S A Key News
7.3 Octapharma AG
  7.3.1 Octapharma AG Corporate Summary
  7.3.2 Octapharma AG Business Overview
  7.3.3 Octapharma AG Guillain-Barre Syndrome Treatment Major Product Offerings
  7.3.4 Octapharma AG Guillain-Barre Syndrome Treatment Revenue in Global Market (2017-2022)
  7.3.5 Octapharma AG Key News
7.4 Kedrion Biopharma Inc
  7.4.1 Kedrion Biopharma Inc Corporate Summary
  7.4.2 Kedrion Biopharma Inc Business Overview
  7.4.3 Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Major Product Offerings
  7.4.4 Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Revenue in Global Market (2017-2022)
  7.4.5 Kedrion Biopharma Inc Key News
7.5 Biotest AG
  7.5.1 Biotest AG Corporate Summary
  7.5.2 Biotest AG Business Overview
  7.5.3 Biotest AG Guillain-Barre Syndrome Treatment Major Product Offerings
  7.5.4 Biotest AG Guillain-Barre Syndrome Treatment Revenue in Global Market (2017-2022)
  7.5.5 Biotest AG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Guillain-Barre Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Guillain-Barre Syndrome Treatment Market Drivers in Global Market
Table 3. Guillain-Barre Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Guillain-Barre Syndrome Treatment in Global Market
Table 5. Top Guillain-Barre Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Guillain-Barre Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Guillain-Barre Syndrome Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Guillain-Barre Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Guillain-Barre Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Guillain-Barre Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Guillain-Barre Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Guillain-Barre Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Guillain-Barre Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Guillain-Barre Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Guillain-Barre Syndrome Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Guillain-Barre Syndrome Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 30. CSL Limited Corporate Summary
Table 31. CSL Limited Guillain-Barre Syndrome Treatment Product Offerings
Table 32. CSL Limited Guillain-Barre Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Grifols S A Corporate Summary
Table 34. Grifols S A Guillain-Barre Syndrome Treatment Product Offerings
Table 35. Grifols S A Guillain-Barre Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Octapharma AG Corporate Summary
Table 37. Octapharma AG Guillain-Barre Syndrome Treatment Product Offerings
Table 38. Octapharma AG Guillain-Barre Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Kedrion Biopharma Inc Corporate Summary
Table 40. Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Product Offerings
Table 41. Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Biotest AG Corporate Summary
Table 43. Biotest AG Guillain-Barre Syndrome Treatment Product Offerings
Table 44. Biotest AG Guillain-Barre Syndrome Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Guillain-Barre Syndrome Treatment Segment by Type in 2021
Figure 2. Guillain-Barre Syndrome Treatment Segment by Application in 2021
Figure 3. Global Guillain-Barre Syndrome Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Guillain-Barre Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Guillain-Barre Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Guillain-Barre Syndrome Treatment Revenue in 2021
Figure 8. By Type - Global Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
Figure 12. US Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
Figure 24. China Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Guillain-Barre Syndrome Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Guillain-Barre Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. CSL Limited Guillain-Barre Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Grifols S A Guillain-Barre Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Octapharma AG Guillain-Barre Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biotest AG Guillain-Barre Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)